FR1455030A - Procédé de préparation de dérivés de la céphalosporine - Google Patents

Procédé de préparation de dérivés de la céphalosporine

Info

Publication number
FR1455030A
FR1455030A FR981074A FR981074A FR1455030A FR 1455030 A FR1455030 A FR 1455030A FR 981074 A FR981074 A FR 981074A FR 981074 A FR981074 A FR 981074A FR 1455030 A FR1455030 A FR 1455030A
Authority
FR
France
Prior art keywords
preparation
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR981074A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Application granted granted Critical
Publication of FR1455030A publication Critical patent/FR1455030A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02—Preparation
    • C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
FR981074A 1963-07-15 1964-07-08 Procédé de préparation de dérivés de la céphalosporine Expired FR1455030A (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB27989/63A GB1101423A (en) 1963-07-15 1963-07-15 Derivatives of 7-aminocephalosporanic acid
GB27990/63A GB1101424A (en) 1963-07-15 1963-07-15 Derivatives of 7-aminocephalosporanic acid
GB1474864 1964-04-09
GB1474764 1964-04-09

Publications (1)

Publication Number Publication Date
FR1455030A true FR1455030A (fr) 1966-04-01

Family

ID=27448261

Family Applications (2)

Application Number Title Priority Date Filing Date
FR981074A Expired FR1455030A (fr) 1963-07-15 1964-07-08 Procédé de préparation de dérivés de la céphalosporine
FR990461A Expired FR4315M (fr) 1963-07-15 1964-10-06

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR990461A Expired FR4315M (fr) 1963-07-15 1964-10-06

Country Status (13)

Country Link
US (2) US3243435A (fr)
BE (2) BE650445A (fr)
BR (1) BR6460800D0 (fr)
CH (2) CH469022A (fr)
CS (1) CS166185B2 (fr)
DE (1) DE1445835B2 (fr)
DK (2) DK124334B (fr)
FR (2) FR1455030A (fr)
GB (2) GB1101423A (fr)
IL (2) IL21639A (fr)
NL (3) NL6408066A (fr)
NO (1) NO128157B (fr)
SE (1) SE335532B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365449A (en) * 1964-07-23 1968-01-23 Fujisawa Pharmaceutical Co 7-(substituted thioacylamino) cephalosporanic acid and derivatives thereof
US3360515A (en) * 1964-07-24 1967-12-26 Fujisawa Pharmaceutical Co 7-(condensed n-containing heterocyclic carbonamido) cephalosporanic acid and derivatives thereof
US3479350A (en) * 1966-12-05 1969-11-18 Glaxo Lab Ltd Process for the manufacture of derivatives of cephalosporin c
GB1277415A (en) * 1968-06-14 1972-06-14 Glaxo Lab Ltd Improvements in or relating to cephalosporin derivatives
US3687948A (en) * 1970-11-23 1972-08-29 Bristol Myers Co 7-{8 D-(a-AMINO-a-PHENYLACETAMIDO){9 -3-(4-METHYL-1,3-OXAZOL-2-YLTHIOMETHYL-3-CEPHEM-4-CARBOXYLIC ACID AND SALTS THEREOF
US4024135A (en) * 1976-03-05 1977-05-17 E. R. Squibb & Sons, Inc. (Carbamoyl)pyridino derivatives of ureidocephalosporins
GB1565941A (en) * 1977-02-08 1980-04-23 Toyama Chemical Co Ltd Process for producing 7-(substituted)amino-3-substituted thiomethyl cephem carboxylic acids
JPS6027677B2 (ja) * 1978-07-06 1985-06-29 富山化学工業株式会社 ７−置換又は非置換アミノ−３−置換チオメチルセフエムカルボン酸類の新規製造法
US4288590A (en) * 1980-02-14 1981-09-08 Bristol-Myers Company 7-[Dα-(4-Hydroxy-1,5-naphthyridine-3-carboxamido)-α-arylacetamido]-3-(N,N-dimethyl-aminomethylpyridinium) methyl-3-cephem-4-carboxylates
ATE31535T1 (de) * 1981-07-17 1988-01-15 Glaxo Group Ltd Cephalosporinverbindungen.
CA2935651A1 (fr) 2007-10-09 2009-04-16 Gladius Pharmaceuticals Corporation Inhibiteurs de beta-lactamase a large spectre
EP2539348A4 (fr) * 2010-02-26 2013-07-24 Gary Igor Dmitrienko Dérivés de la céphalosporine utiles comme inhibiteurs de la -lactamase et leurs compositions et procédés d'utilisation

Also Published As

Publication number Publication date
GB1101424A (en) 1968-01-31
US3261832A (en) 1966-07-19
GB1101423A (en) 1968-01-31
FR4315M (fr) 1966-08-01
NO128157B (fr) 1973-10-08
BR6460800D0 (pt) 1973-08-02
NL130098C (fr)
IL21640A (en) 1968-04-25
DE1445835A1 (de) 1969-01-09
CH469022A (de) 1969-02-28
DK120544C (da) 1971-11-08
SE335532B (fr) 1971-06-01
NL6408066A (fr) 1965-01-18
BE650445A (fr) 1965-01-11
DE1445835B2 (de) 1976-04-22
CS166185B2 (fr) 1976-01-29
BE650444A (fr) 1965-01-11
DK124334B (da) 1972-10-09
CH469739A (de) 1969-03-15
DK120544B (fr) 1971-06-14
NL6408067A (fr) 1965-01-18
US3243435A (en) 1966-03-29
IL21639A (en) 1968-04-25

Similar Documents

Publication Publication Date Title
CH467255A (fr) Procédé de préparation de dérivés gonatriéniques
FR1455030A (fr) Procédé de préparation de dérivés de la céphalosporine
CH438309A (fr) Procédé de préparation de dérivés du nitro-5 pyrrole
CH460750A (fr) Procédé de préparation de dérivés d'aminoidane
OA01087A (fr) Procédé de préparation de nouveaux dérivés de benzamidobenzanilide
CH433272A (fr) Procédé de préparation de dérivés de la tétracycline
CH461464A (fr) Procédé de préparation de dérivés fonctionnels du méthylène-2-propanediol-1-3
FR1532222A (fr) Procédé de préparation de dérivés de la pénicilline
FR1320300A (fr) Procédé de préparation de dérivés de la 3-phényl-7-hydroxy-chromone
CH453347A (fr) Procédé de préparation de dérivés stéroïdes
CH410956A (fr) Procédé de préparation de dérivés de céphalosporines
FR1372054A (fr) Procédé de préparation de dérivés de purine
FR1416000A (fr) Procédé de préparation de dérivés de la purine
FR1466241A (fr) Procédé de préparation de dérivés de 17alpha-acyl-16alpha-hydroxy-prégnènes
CH436257A (fr) Procédé de préparation de dérivés aminoacétyléniques
FR1326731A (fr) Procédé pour la préparation de dérivés de polyhydrophénanthrènes
FR1355727A (fr) Procédé de préparation de dérivés de thiazole
FR1396655A (fr) Procédé de préparation de dérivés de lysine
FR1361651A (fr) Procédé de préparation de nouveaux dérivés de la céphalosporine
FR1508029A (fr) Procédé de préparation de dérivés de 16beta-méthyl-corticostérone
FR1433310A (fr) Procédé de préparation de dérivés dibenzocycloheptadiéniques
FR1365358A (fr) Procédé de préparation de dérivés 19-nor-stéroïdes
FR1355154A (fr) Procédé de préparation de dérivés 5-nitrofuraniques
FR1417553A (fr) Procédé de préparation de dérivés mercapto-amino-triaziniques
FR1411727A (fr) Procédé de préparation de dérivés de 16-alcoyl-progestérones